Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET)

PHASE2CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

February 5, 2021

Primary Completion Date

June 1, 2022

Study Completion Date

July 13, 2022

Conditions
Ulcerative Colitis
Interventions
DRUG

AMT-101 (oral)

AMT 101 is orally administered biological therapeutic taken once daily

OTHER

Placebo (oral)

Orally administered placebo comparator taken once daily

COMBINATION_PRODUCT

Humira (adalimumab)

Humira comparator is administered subcutaneously, on Humira frequency schedule.

Trial Locations (18)

10003

"Medical Center of Limited Liability Company Medibor, Department of Daycare, Day Surgery with Intensive Care Ward", Zhytomyr

21028

"Municipal non-profit enterprise Vinnytsia Regional Clinical Hospital named after M.I. Pirogov of Vinnytsia Regional Council, Regional Specialized Clinical gastroenterological Center", Vinnytsia

21029

"Municipal non-profit enterprise Vinnytsya City Clinical Hospital No1, Gastroenterology Department", Vinnytsia

0112

Arensia Exploratory Medicine GmbH Georgia, Tbilisi

1105 AZ

Academic Medical Center, Amsterdam

85-079

NZOZ Vitamed, Bydgoszcz

89-600

Centrum Medyczne LukaMed Joanna Łuka-Wendrowska, Chojnice

86-300

Centrum Medyczne CLW-med Aneta Cichomska , Joanna Łuka -Wendrowska, Grudziądz

44-190

Indywidualna Specjalistyczna Praktyka Lekarska Maciej Zymla, Knurów

05-500

Centrum Innowacyjnych Terapii Sp. z o.o. Oddzial w Piasecznie, Piaseczno

35-326

Centrum Medyczne Medyk, Rzeszów

43-100

H.T. Centrum Medyczne - Endoterapia, Tychy

03-580

Niepubliczny Zakład Opieki Zdrowotnej Vivamed Jadwiga Miecz, Warsaw

03-712

Bodyclinic sp z o.o. Sp. Kom., Warsaw

50-449

Centrum Medyczne Melita Medical, Wroclaw

01135

"Medical Center of Limited Liability Company Harmoniya Krasy", Kyiv

02091

"Medical Center OK!Clinic+ of International Institute of Clinical Research LLC, Gastroenterology and Hepatology unit of Hospital department", Kyiv

04078

"Municipal non-profit enterprise of Kyiv Regional Council Kyiv Regional Hospital, Therapeutic Department", Kyiv

Sponsors
All Listed Sponsors
lead

Applied Molecular Transport

INDUSTRY

NCT05372939 - Study of the Efficacy and Safety of AMT-101 in Combination With Adalimumab in Subjects With Ulcerative Colitis (MARKET) | Biotech Hunter | Biotech Hunter